Apotex Inc.

He says, I want to arm you with the truth.

Jonathan was 37 years old, an engineer by training, and the one Sherman child who had been interested in business, though not to his father's lasting disappointment in Apotex.

I touched upon his business ventures in Part 3, the self-storage chain Green Storage, as well as some cottages and marinas that he owned.

Jonathan said that his father had lent him $125 million over the years, interest-free, through SureFam, the family's holding company.

He wrote, I don't want to meet with you and Adam.

You are my son.

Jonathan then called himself the heir apparent, and Barry agreed that he was my son and heir to the empire, but complained about his unwillingness and apparent disinterest in Apotex, and added that his son's hostility persist.

The meeting never happened.

So that recent sell off in the stock to me is even a greater opportunity to add to it.

And stock number five, Apotex.

OK, this one's interesting, more of a recent opportunity for investors because they had a high profile IPO, even though they've been around for many years, kind of known in the generic drug market.

But what stands out with you with this one?

Do you remember them? They were a billionaire couple, the pharma owners that wound up dead in their home in a murder-suicide.

Yeah, they owned a company called Apotex who supplied generic drugs to the Clinton Foundation in Haiti and Rwanda.

Which, you know, turned out to be a big scandal because the AIDS drugs were defective and watered down.

And the company that sold them was the company that Barry and Honey Sherman owned.

We are in the process of attaining or have executed 20 judicial authorizations and searches.

Legal complexities in some executions have been challenging given the litigious nature of Barry Sherman's businesses, in particular the search and seizure of electronics in Barry Sherman's workspace at Apotex.

Two residential properties belonging to the Shermans have been searched.

The primary Sherman residence is a three-story family dwelling of a size warranting six weeks of searching, forensic review and seizing of evidence.

There are two more pieces of news that would break that day, though neither came from that podium.

That morning, the police had handed the keys to 50 Old Colony Road back to the Sherman family, and before Gomes even started speaking, a team of private investigators in white forensic suits was already moving through the house.

And across the city, Apotex, the generic drug company that Barry Sherman had built over decades, announced that its president and chief executive, Jeremy Desai, was leaving to, "...pursue other opportunities." A reporter asked an Apotex spokesman whether the timing meant anything, but he said, "...pure coincidence.

We had no idea the police were going to make that announcement." 42 days earlier, standing on a lawn on Old Colony Road on the night that the bodies were found, Toronto detective Brandon Price had told reporters that police were not currently seeking or looking for an outstanding suspect.

Then, Detective Price asks about anything upsetting that had happened recently, and Kay starts talking about the company.

There's a lawsuit, he says, from Teva, the Israeli generic drug giant involving Apotex's chief executive, a man named Jeremy Desai.

That lawsuit has apparently hurt employee morale.

And then Jack Kay says something that, by the standards of a 35-year partnership, is pretty remarkable.

Jack Kay believed that for the good of the company, Jeremy Desai, their CEO, should have been let go.

But Barry would not do it.

Kay tells Detective Price that one to two weeks beforehand, Apotex had had some layoffs, and there was a second phase of layoffs planned for January.

He says that the company is in a tenuous situation, and that it means more stress for the executives, Barry included.

He asks, hello, Keith.

Comments on Apotex, APTX going forward.

OK, relatively new stock on the market.

So hard to get.

And that's also important for some people.

For Canada, just a note on Canada, generic semaglutide, which remember is just GLP-1, launched in Canada in May of this year from Apotex and Dr. Reddy's at roughly a third of the price of the brand name Ozempic.

Canada got there first among the G7.

And the reason is remarkable because Novo Nordisk let the Canadian patent lapse over an unpaid maintenance fee of about $250, which is hilarious.

And so Canada was like snoozy lose.

Now we can make a generically because there's no patent on this.

And so two companies have already done it, Apotex and Dr. Reddy's, and it's a third of the price of what Ozempic did.

so ozempic novo nordisk literally guys have lost probably millions and millions and millions of dollars over this one thing that they didn't do in canada but for all the canadians you can go get generic semi-glutide for the we are the first like country in the g7 to be able to do this so if you want to try it it's literally the any it's the cheapest in canada out of everywhere mind you There are side effects with it.

Health Canada approved the country's first generic semaglutide referencing Ozempic in April 2026.

Then in June, it approved Apotex's said Maya, the first generic semaglutide, specifically referencing Wegovi for weight management.

India has also seen multiple generic semaglutide launches following the March patent expiry.

I would call them generic semaglutide products where the regulator does, rather than casually using biosimilar for all of them.

We have an email from Gene.

He says, could you please ask your guest thoughts on Apotex, which is a pharma company that recently went public, a Canadian-based company.

And what do you think about it?

Well, listen, this is your, you know, we don't have a real big space of these in Canada.

Please do not suffer in silence.

On Monday, January 15th, 2018, a month to the day after the bodies of Barry and Honey Sherman were found in their home, two Toronto homicide detectives walk into the head office of Apotex on Signet Drive.

Detective Brandon Price and Detective Constable Christy Devine had a search warrant granted by a judge that same day.

It covered two rooms, the office of the company's late founder and chairman, Bernard Sherman, and the small laboratory right next to it, where even at 75, he still liked to work out drug formulations himself.

Standing with them were lawyers from Goodman's LLP, the firm representing Apotex and the Sherman Estates, who had spent the past four weeks making sure that the police did not read anything they weren't supposed to.

The affidavit the detectives swore to get this warrant is very clear about what they're hoping to find.

A month in, suicide is still, in the words of one of those affidavits, a significant possibility.

So he decided to finally write down some thoughts that had been forming in his mind for a while.